Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: Towards a mechanism of action

被引:124
作者
deVerdiere, AC
Dubernet, C
Nemati, F
Soma, E
Appel, M
Ferte, J
Bernard, S
Puisieux, F
Couvreur, P
机构
[1] CTR ETUD PHARMACEUT,CNRS,URA 1218,F-92296 CHATENAY MALABR,FRANCE
[2] CTR ETUD PHARMACEUT,CNRS,URA 1843,F-92296 CHATENAY MALABR,FRANCE
关键词
nanoparticle; polyalkylcyanoacrylate; doxorubicin; multidrug resistance; ion pair; P388;
D O I
10.1038/bjc.1997.362
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Polyalkylcyanoacrylate (PACA) nanoparticles loaded with doxorubicin allowed multidrug resistance to be overcome in vitro. However, increased cytotoxicity is not always correlated with an increased level of intracellular drug. Although we have previously shown that PACE nanoparticles are not endocytosed by tumour cells, we report here that a direct interaction between nanoparticles and cells is a necessary requirement for overcoming resistance. In addition, the results showed that the degradation products of PACA (mainly polycyanoacrylic acid) in the presence of doxorubicin are able to increase both accumulation and cytotoxicity, thus suggesting the formation of a doxorubicin-polycyanoacrylic acid ion pair, It is therefore concluded that resistance is overcome as a result of both the adsorption of nanoparticles to the cell surface and increased doxorubicin diffusion by the accumulation of an ion pair at the plasma membrane.
引用
收藏
页码:198 / 205
页数:8
相关论文
共 30 条
  • [1] THE MULTIDRUG RESISTANCE (MDR1) GENE-PRODUCT FUNCTIONS AS AN ATP CHANNEL
    ABRAHAM, EH
    PRAT, AG
    GERWECK, L
    SENEVERATNE, T
    ARCECI, RJ
    KRAMER, R
    GUIDOTTI, G
    CANTIELLO, HF
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) : 312 - 316
  • [2] BENNIS S, 1993, EUR J CANCER, V30, P106
  • [3] BOGUSH T, 1995, CANCER CHEMOTH PHARM, V35, P501, DOI 10.1007/s002800050268
  • [4] DOXORUBICIN-LOADED NANOSPHERES BYPASS TUMOR-CELL MULTIDRUG RESISTANCE
    CUVIER, C
    ROBLOTTREUPEL, L
    MILLOT, JM
    LIZARD, G
    CHEVILLARD, S
    MANFAIT, M
    COUVREUR, P
    POUPON, MF
    [J]. BIOCHEMICAL PHARMACOLOGY, 1992, 44 (03) : 509 - 517
  • [5] DEVERDIERE AC, 1994, CANCER CHEMOTH PHARM, V33, P504
  • [6] DUJEDA PK, 1995, ARCH BIOCHEM BIOPHYS, V319, P309
  • [7] DNA-CONTAINING LIPOSOMES AS A MODEL FOR THE STUDY OF CELL-MEMBRANE PERMEATION BY ANTHRACYCLINE DERIVATIVES
    FREZARD, F
    GARNIERSUILLEROT, A
    [J]. BIOCHEMISTRY, 1991, 30 (20) : 5038 - 5043
  • [8] GOTTESMAN MM, 1988, J BIOL CHEM, V263, P12163
  • [9] BIOCHEMISTRY OF MULTIDRUG-RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
    GOTTESMAN, MM
    PASTAN, I
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 : 385 - 427
  • [10] GUNN RB, 1978, PHYSL MEMBRANE DISOR, P243